Eli Lilly stock is climbing higher ahead of an FDA meeting to discuss its Alzheimer's treatment. Is LLY stock a buy right now?
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GSK and Biogen (BIIB) are in the spotlight following litigation updates and drug approval, respectively.